36 research outputs found
CT Density in Lung Cancer Patients After Radiotherapy Sensitized by Metoclopramide : A Subgroup Analysis of a Randomized Trial
Purpose: To investigate the lung tissue response measured with computed tomography (CT) after radiotherapy (RT) combined
with metoclopramide.
Patients and Methods: Patients with non-small cell lung cancer (tumor stage IIIA and IIIB), included in a multicenter, randomized
phase III trial investigating the use of metoclopramide as a radiosensitizing agent, were examined with repetitive post-RT
CT scans. The analysis comprised data up to 100 days after RT for a subgroup of 16 patients treated with a total dose of 60 Gy
given in 1.82 Gy per fraction.
Results: Large radiation doses to subvolumes were associated with denser lung tissue measured with CT (p < 0.001). Opposed
to this finding, the volume of lung tissue irradiated with significant doses (V40Gy) was negatively correlated with the average
increase in lung tissue density (p = 0.003). Patients randomized to metoclopramide injections also experienced less increase in
lung tissue density (p = 0.01).
Conclusion: There was an increase in the density of irradiated lung tissue with radiation dose and time after RT. Metoclopramide
and significant radiation doses to larger lung volumes (V40Gy) seemed to protect against fibrosis development.Ziel: Computertomographische (CT) Messung der Strahlenreaktion in Lungengewebe nach Strahlentherapie in Kombination mit
Metoclopramid.
Patienten und Methodik: Patienten mit nichtkleinzelligem Bronchialkarzinom (Tumorstadium IIIA und IIIB), die in eine randomisierte,
multizentrische Phase-III-Studie zur Untersuchung des strahlensensitivierenden Effekts von Metoclopramid eingeschlossen
waren, wurden mittels wiederholter posttherapeutischer CTs untersucht. Verlaufskontrolldaten bis 100 Tage nach Beendigung
der Strahlentherapie einer Untergruppe von 16 Patienten, die mit einer Gesamtdosis von 60 Gy, appliziert in Tagesdosen
von 1,82 Gy, behandelt wurden, standen für die Analyse zur Verfügung.
Ergebnisse: Hohe Strahlendosen auf Teilvolumina resultierten in höherer CT-Dichte im bestrahlten Lungengewebe (p < 0,001).
Im Gegensatz dazu korrelierte das mit signifikanter Dosis bestrahlte Lungenvolumen (V40Gy) negativ mit der Zunahme der CTDichte
im bestrahlten Lungengewebe (p = 0,003). Bei Patienten, die in den Therapiarm mit Metoclopramid randomisiert wurden,
war eine weniger ausgeprägte Zunahme der CT-Dichte im bestrahlten Lungengewebe zu verzeichnen (p = 0,01).
Schlussfolgerung: Es fand sich ein Zusammenhang zwischen der Zunahme der gemessenen CT-Dichte im bestrahlten Lungengewebe,
der applizierten Strahlendosis und der Zeit nach Bestrahlung. Metoclopramid und das mit signifikanter Dosis bestrahlte
Lungenvolumen (V40Gy) scheinen einen protektiven Effekt auf die Entwicklung einer Lungenfibrose zu haben
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy
<p>Abstract</p> <p>Background</p> <p>This study was conducted in order to elucidate metabolic differences between human rectal cancer biopsies and colorectal HT29, HCT116 and SW620 xenografts by using high-resolution magnetic angle spinning (MAS) magnetic resonance spectroscopy (MRS) and for determination of the most appropriate human rectal xenograft model for preclinical MR spectroscopy studies. A further aim was to investigate metabolic changes following irradiation of HT29 xenografts.</p> <p>Methods</p> <p>HR MAS MRS of tissue samples from xenografts and rectal biopsies were obtained with a Bruker Avance DRX600 spectrometer and analyzed using principal component analysis (PCA) and partial least square (PLS) regression analysis.</p> <p>Results and conclusion</p> <p>HR MAS MRS enabled assignment of 27 metabolites. Score plots from PCA of spin-echo and single-pulse spectra revealed separate clusters of the different xenografts and rectal biopsies, reflecting underlying differences in metabolite composition. The loading profile indicated that clustering was mainly based on differences in relative amounts of lipids, lactate and choline-containing compounds, with HT29 exhibiting the metabolic profile most similar to human rectal cancers tissue. Due to high necrotic fractions in the HT29 xenografts, radiation-induced changes were not detected when comparing spectra from untreated and irradiated HT29 xenografts. However, PLS calibration relating spectral data to the necrotic fraction revealed a significant correlation, indicating that necrotic fraction can be assessed from the MR spectra.</p
Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
Strengere kontroll av kunnskapsoverføring gir dreining av internasjonalt forskningssamarbeid
I disse dager jobber vi med høringssvar til de reviderte retningslinjene for kontroll av kunnskapsoverføring, det såkalte eksportkontrollregelverket. Som et mørkt bakteppe, ligger krigen i Ukraina og myndighetenes årlige trusselvurdering
Strengere kontroll av kunnskapsoverføring gir dreining av internasjonalt forskningssamarbeid
Source: https://www.nordlys.no/.I disse dager jobber vi med høringssvar til de reviderte retningslinjene for kontroll av kunnskapsoverføring, det såkalte eksportkontrollregelverket. Som et mørkt bakteppe, ligger krigen i Ukraina og myndighetenes årlige trusselvurdering
CT Density in Lung Cancer Patients After Radiotherapy Sensitized by Metoclopramide : A Subgroup Analysis of a Randomized Trial
Purpose: To investigate the lung tissue response measured with computed tomography (CT) after radiotherapy (RT) combined
with metoclopramide.
Patients and Methods: Patients with non-small cell lung cancer (tumor stage IIIA and IIIB), included in a multicenter, randomized
phase III trial investigating the use of metoclopramide as a radiosensitizing agent, were examined with repetitive post-RT
CT scans. The analysis comprised data up to 100 days after RT for a subgroup of 16 patients treated with a total dose of 60 Gy
given in 1.82 Gy per fraction.
Results: Large radiation doses to subvolumes were associated with denser lung tissue measured with CT (p < 0.001). Opposed
to this finding, the volume of lung tissue irradiated with significant doses (V40Gy) was negatively correlated with the average
increase in lung tissue density (p = 0.003). Patients randomized to metoclopramide injections also experienced less increase in
lung tissue density (p = 0.01).
Conclusion: There was an increase in the density of irradiated lung tissue with radiation dose and time after RT. Metoclopramide
and significant radiation doses to larger lung volumes (V40Gy) seemed to protect against fibrosis development
The elimination of low-dose hyper-radiosensitivity by transfer of irradiated-cell conditioned medium depends on dose rate
Early Changes in Apparent Diffusion Coefficient Predict the Quantitative Antitumoral Activity of Capecitabine, Oxaliplatin, and Irradiation in HT29 Xenografts in Athymic Nude Mice
AbstractPURPOSE: The purpose of this study was to evaluate the possible use of changes in apparent diffusion coefficient (ADC) measured by magnetic resonance imaging for pretreatment prediction and early detection of tumor response in a mouse model during fractionated chemoradiotherapy. MATERIALS AND METHODS: Athymic mice with bilateral HT29 xenografts on rear flanks were allocated into three groups: control, capecitabine, and capecitabine and oxaliplatin. The left flanks of the mice Received daily irradiation. T2 and diffusion images were acquired before therapy and weekly for the following 9 weeks. Pretreatment and changes in ADC were calculated and compared with tumor doubling growth delay. RESULTS: No correlations between pretreatment ADC and changes in tumor volumes after therapy were seen. All treated tumors, except those receiving capecitabine (P = .06), showed increased mean tumor ADC values 11 days after initialization of therapy (P < .05) before returning to pretreatment values within 5 days posttherapy (day 18 after onset of therapy). This increase in mean tumor ADC showed a strong positive correlation (r = 0.92, P < .01) with mean tumor doubling growth delay. CONCLUSIONS: Pretreatment ADC values did not predict the effectiveness of therapy, whereas early changes in mean ADC quantitatively correlated with treatment outcome